🇺🇸 FDA
Patent

US 7052703

T-cell receptorγ alternate reading frame protein, (TARP) and uses thereof

granted A61KA61K38/00A61K39/00

Quick answer

US patent 7052703 (T-cell receptorγ alternate reading frame protein, (TARP) and uses thereof) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon May 25 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue May 30 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 25 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
31
CPC classes
A61K, A61K38/00, A61K39/00, A61K40/11, A61K40/32